ECL vs XAGE: stock comparison and AI forecast
Ecolab Inc. (ECL) and Longevity Health Holdings, Inc. (XAGE) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ECL Ecolab Inc.
- Price
- $300.68 +17.2% · 6M
- Market Cap
- $84.33B
- P/E Ratio
- 40.9x
- Size
- large-cap
- AI Forecast
XAGE Longevity Health Holdings, Inc.
- Price
- $0.11 -65.6% · 6M
- Market Cap
- $270K
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ECL is 312337.2 times larger than XAGE by market capitalization ($84.33B against $270K).
- Over the last six months ECL returned +17.2% and XAGE -65.6%.
- ECL turns 12.0% of its revenue into net income, against -404.8% for XAGE.
- ECL yields 0.97% in dividends; XAGE pays none.
- Both companies share the SEC industry classification Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ECL | XAGE |
|---|---|---|
| Market Cap | $84.33B | $270K |
| P/E Ratio | 40.91x | – |
| P/B Ratio | 8.09x | – |
| Dividend Yield | 0.97% | – |
| EPS | $7.35 | $-4.06 |
| Book Value/Share | $37.17 | – |
| Revenue/Share | $61.94 | $0.68 |
| FCF/Share | $6.40 | – |
Profitability & Margins
| Metric | ECL | XAGE |
|---|---|---|
| ROE | 20.0% | – |
| ROA | 6.7% | -647.0% |
| ROIC | 11.7% | 67.9% |
| Gross Margin | 43.9% | 59.0% |
| Operating Margin | 16.7% | -343.6% |
| Net Margin | 12.0% | -404.8% |
| EBT Margin | 15.0% | -402.7% |
| Tax Rate | 19.5% | -0.5% |
Financial Health
| Metric | ECL | XAGE |
|---|---|---|
| Current Ratio | 1.11x | 0.07x |
| Quick Ratio | 0.84x | 0.01x |
| D/E Ratio | 1.98x | – |
| Financial Leverage | 2.98x | – |
| Interest Coverage | 8.1x | -336.3x |
| Working Capital | $720M | -$9M |
Cash Flow
| Metric | ECL | XAGE |
|---|---|---|
| Operating Cash Flow | $3.03B | -$2M |
| Free Cash Flow | $1.80B | – |
| Capital Spending | -$1.23B | – |
| OCF Growth YoY | 15.2% | – |
| FCF Growth YoY | 15.6% | – |
| FCF/Sales | 10.3% | – |
| CapEx/Sales | 7.1% | – |
Operational Efficiency
| Metric | ECL | XAGE |
|---|---|---|
| Asset Turnover | 0.56x | 1.60x |
| Receivables Turnover | 4.6x | 86.3x |
| Inventory Turnover | 5.5x | 1.1x |
| Fixed Assets Turnover | 3.8x | 22.3x |
| Days Sales Outstanding | 80 days | 4 days |
| Days Inventory | 66 days | 320 days |
| Payables Period | 88 days | 2659 days |
| Cash Conversion Cycle | 58 days | -2335 days |
Income Statement
| Metric | ECL | XAGE |
|---|---|---|
| Total Revenue | $17.37B | $2M |
| Operating Income | $2.90B | -$6M |
| Net Income | $2.08B | -$7M |
| R&D Expense | – | $490K |
| SG&A Expense | $4.48B | – |
| Cost of Goods Sold | $9.74B | $690K |
Dividend & Shareholder Information
| Metric | ECL | XAGE |
|---|---|---|
| Dividends Per Share | $2.92 | – |
| Payout Ratio | 39.7% | – |
| Shares Outstanding | 280M | 2M |
| Net Income Growth | 4.9% | – |
| EPS Growth | 5.8% | – |
ECL vs XAGE: stock comparison and AI forecast
Which is bigger, ECL or XAGE?
ECL is 312337.2 times larger than XAGE by market capitalization ($84.33B against $270K).
Which stock performed better over the last six months, ECL or XAGE?
Over the last six months ECL returned +17.2% and XAGE -65.6%.
Which one does Intratio's AI model rank higher, ECL or XAGE?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.